ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy's shares slide 7% after delay in semaglutide supplies over quality concerns
Dr Reddy's shares fell sharply on Thursday after the company delayed commercial supplies of its semaglutide product due to a quality issue involving the active pharmaceutical ingredient (API). The company said patient safety and regulatory filings remain u
Announcement as on 09 July 2026

Generics must not be imperiled over data protection: Satish Reddy, Chairman, Dr Reddy's Laboratories
Dr Reddy's chairman, Satish Reddy, has raised concerns about compromising India's competitive edge in generics for foreign investments. He stresses the importance of aligning capital with developmental needs and enhancing collaboration between academia and
Announcement as on 02 July 2026

Dr Reddys Share Price Live Updates: Dr. Reddys shows a slight gain in today's trading

Announcement as on 22 June 2026

Dr Reddy's launches oral semaglutide biosimilar Obeda in India
Dr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This innovative treatment offers patients the ease of a once-daily oral dosage, available in various strengths to effective
Announcement as on 20 May 2026

Dr Reddy’s launches oral semaglutide in India
Dr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three tablet strengths for daily use. This launch expands access to advanced diabetes care. Dr Reddys is the second Indian co
Announcement as on 20 May 2026

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 12.21
  • 12Day Average: 12.22
  • 20Day Average: 12.06
  • 50Day Average: 12.96
  • 100Day Average: 13.16
  • 150Day Average: 13.44
  • 200Day Average: 13.54

RDY Indicators & signals

Indicator MACD (12,26,9)

12.19, 12.35, -0.23
Indicator MACD is in negative zone

Indicator ADX (14)

17.65, 25, 35.71
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
19 Wed Aug 2026 12.11 11.99 to 12.22 -0.33% 1.34 times
18 Tue Aug 2026 12.15 12.06 to 12.21 0.33% 1.26 times
17 Mon Aug 2026 12.11 12.06 to 12.24 -1.3% 0.84 times
14 Fri Aug 2026 12.27 12.22 to 12.39 -1.21% 0.93 times
13 Thu Aug 2026 12.42 12.37 to 12.51 0.24% 1.15 times
12 Wed Aug 2026 12.39 12.33 to 12.42 -0.48% 0.91 times
11 Tue Aug 2026 12.45 12.42 to 12.58 2.47% 0.97 times
10 Mon Aug 2026 12.15 11.58 to 12.29 -0.57% 0.81 times
07 Fri Aug 2026 12.22 12.12 to 12.26 0.91% 1.05 times
06 Thu Aug 2026 12.11 12.05 to 12.22 -0.25% 1.05 times
05 Wed Aug 2026 12.14 12.13 to 12.24 0.33% 1.04 times
04 Tue Aug 2026 12.10 11.97 to 12.21 0.25% 0.84 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top